Bausch & Lomb Americas Inc.
NDC labeler code: 82260
What is a labeler?
The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.
Official FDA data only
Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.
Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.
Prescription medicines
- TimololTimoptic in Ocudose, Timoptic, Timolol Gfs · 6 products
- Loteprednol etabonateLotemax, Alrex, Lotemax Sm · 3 products
- PhenylephrineImmphentiv, Biorphen · 2 products
- Tetracaine hydrochloride1 product
- AtropineAtropen Auto-Injector, Isopto Atropine · 1 product
- BesifloxacinBesivance · 1 product
- Fluorescein sodium and benoxinate hydrochlorideAltafluor · 1 product
- Loteprednol etabonate and tobramycinZylet · 1 product
- BepotastineBepreve · 1 product
- BromfenacBromsite 0.075%, Prolensa · 1 product
FDA applications for these products
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| March 15, 2022 | NDA213581 | Atropine ATROPINE SULFATE | Bausch and Lomb Inc |
| March 9, 2020 | NDA211039 | Fluorescein sodium and benoxinate hydrochloride FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE | Bausch Lomb Ireland |
| March 12, 2019 | NDA210821 | Tetracaine hydrochloride TETRACAINE HYDROCHLORIDE | Bausch Lomb Ireland |
| April 5, 2013 | NDA203168 | Bromfenac PROLENSA | Bausch and Lomb |
| March 21, 2013 | NDA203510 | Phenylephrine PHENYLEPHRINE HYDROCHLORIDE | Paragon Bioteck |
| September 28, 2012 | NDA202872 | Loteprednol etabonate LOTEMAX | Bausch and Lomb Inc |
| September 8, 2009 | NDA022288 | Bepotastine BEPREVE | Bausch and Lomb Inc |
| May 28, 2009 | NDA022308 | Besifloxacin BESIVANCE | Bausch and Lomb |
| December 14, 2004 | NDA050804 | Loteprednol etabonate and tobramycin ZYLET | Bausch and Lomb |
| June 4, 2004 | NDA021516 | Timolol ISTALOL | Bausch and Lomb |
| March 9, 1998 | NDA020583 | Loteprednol etabonate LOTEMAX | Bausch and Lomb |
| March 9, 1998 | NDA020803 | Loteprednol etabonate ALREX | Bausch and Lomb |
| November 4, 1993 | NDA020330 | Timolol TIMOPTIC-XE | Bausch and Lomb Inc |
| November 5, 1986 | NDA019463 | Timolol TIMOPTIC IN OCUDOSE | Bausch and Lomb Inc |
| August 17, 1978 | NDA018086 | Timolol TIMOPTIC | Bausch and Lomb Inc |
The sponsor is the company that holds the FDA application; it can differ from the labeler.
Recall timeline
No recall of these products (by NDC code) appears in the FDA enforcement reports.
Next steps
- Find a pharmacy near youAsk which company made your medicine and whether it is recalled
- Latest FDA drug recallsAll companies, newest first
- All drug companiesA to Z
- All prescription drugs A to ZSearch by generic, brand or Spanish name
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026